Phase II clinical trials
Phase II clinical trials are a second stage in the process of clinical trials conducted to assess the effectiveness and side effects of a new drug or treatment. They are typically conducted on a larger group of people than Phase I trials, and are designed to determine the optimal dose and schedule for the drug or treatment.
Overview[edit | edit source]
Phase II clinical trials are a critical step in the development of new treatments. They are designed to assess the efficacy and side effects of a new drug or treatment in a larger group of people than Phase I trials. The main goal of Phase II trials is to determine the optimal dose and schedule for the drug or treatment.
Phase II trials are typically randomized, meaning that participants are randomly assigned to receive either the new treatment or a placebo or standard treatment. This helps to ensure that any differences in outcomes are due to the treatment itself and not other factors.
Process[edit | edit source]
The process of a Phase II clinical trial typically involves the following steps:
- Informed consent: Before participating in a trial, individuals must be fully informed about the potential risks and benefits of the trial and must give their consent to participate.
- Randomization: Participants are randomly assigned to receive either the new treatment or a placebo or standard treatment.
- Treatment: Participants receive the treatment as specified by the trial protocol.
- Monitoring: Participants are closely monitored for side effects and responses to the treatment.
- Data analysis: The data collected during the trial is analyzed to determine the effectiveness and side effects of the treatment.
Outcomes[edit | edit source]
The outcomes of a Phase II clinical trial can vary. If the trial shows that the treatment is effective and has acceptable side effects, it may move on to Phase III trials, which involve even larger groups of people. If the trial shows that the treatment is not effective or has unacceptable side effects, it may be discontinued.
See also[edit | edit source]
- Clinical trial
- Phase I clinical trials
- Phase III clinical trials
- Phase IV clinical trials
- Randomized controlled trial
| Phase II clinical trials Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
